Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
26.7M
-
Shares change
-
-1.99M
-
Total reported value, excl. options
-
$44.9M
-
Value change
-
-$6.02M
-
Put/Call ratio
-
0.25
-
Number of buys
-
46
-
Number of sells
-
-67
-
Price
-
$1.68
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2023
148 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.7M shares
of 54.8M outstanding shares and own 48.8% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.71M shares), VANGUARD GROUP INC (2.6M shares), DISCIPLINED GROWTH INVESTORS INC /MN (1.77M shares), Chescapmanager LLC (1.76M shares), FARALLON CAPITAL MANAGEMENT LLC (1.67M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.44M shares), GEODE CAPITAL MANAGEMENT, LLC (973K shares), Clearbridge Investments, LLC (972K shares), STATE STREET CORP (925K shares), and IQ EQ FUND MANAGEMENT (IRELAND) Ltd (849K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.